Premium
Evaluation of Score for Neonatal Acute Physiology and Perinatal Extension II and Clinical Risk Index for Babies with additional parameters
Author(s) -
Asker Hüseyin Selim,
Satar Mehmet,
Yıldızdaş Hacer Yapıcıoğlu,
Mutlu Birgül,
Özyurt Banu Mutlu,
İpek Mehmet Şah,
Sivaslı Ercan,
Taviloğlu Şafak,
Çelik Yalçın,
Özcan Kenan,
Burgut Refik,
Ünal İlker
Publication year - 2016
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.12973
Subject(s) - medicine , gestational age , pediatrics , snap , neonatal mortality , neonatal intensive care unit , corticosteroid , scoring system , mortality rate , pregnancy , infant mortality , population , genetics , computer graphics (images) , environmental health , computer science , biology
Background The aim of this study was to determine mortality risk by calculating Score for Neonatal Acute Physiology and Perinatal Extension II (SNAP‐PE‐II) and Clinical Risk Index for Babies (CRIB) score, and evaluate prediction of the effects of antenatal corticosteroid and surfactant treatment on mortality. Methods This multicenter study was conducted simultaneously in five different centers in four different provinces in Southern Turkey between July 2012 and July 2013. A total of 1668 inborn subjects hospitalized in the neonatal intensive care unit within the first 12 h of delivery, and meeting the selection criteria, were included in the study, and CRIB and SNAP‐PE‐II were used to determine mortality. Results The SNAP‐PE‐II scoring system was applied to all patients, and the CRIB scoring system was used for 310 newborns with gestational age <32 weeks and weighing <1500 g. Of the 1668 patients, 188 died (mortality rate, 11.3%). Cut‐off was found to vary with center, which changed specificity and sensitivity of the mortality scores. SNAP‐PE‐II significantly predicted mortality ( P < 0.05) compared with CRIB. SNAP‐PE‐II also successfully predicted mortality in the group receiving antenatal corticosteroid compared with the group not receiving antenatal corticosteroid. Conclusion SNAP‐PE‐II was a significant predictor of mortality in newborns with birthweight <1500 g compared with CRIB, and assessment of antenatal corticosteroid use in conjunction with SNAP‐PE‐II increased the accuracy of the prediction of mortality.